A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty

Completed · Phase 2 · Has a placebo group

Conditions studied: Acute Pain

In brief

The purpose of this study is to evaluate the efficacy and safety of VX-548 doses in treating acute pain after an abdominoplasty.

Key facts

Study ID

NCT05034952

Run by

Vertex Pharmaceuticals Incorporated

People needed

303

Starts

2021-08-30

Expected to finish

2021-12-21

Last updated by the study team

2024-12-27

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arizona Research Center — Phoenix, Arizona, United States
• Lotus Clinical Research — Pasadena, California, United States
• Chesapeake Research Group — Pasadena, Maryland, United States
• Midwest Clinical Research Center — Dayton, Ohio, United States
• First Surgical Hospital — Bellaire, Texas, United States
• Endeavor Clinical Trials — San Antonio, Texas, United States
• JBR Clinical Research — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.